Exclusive Content
AstraZeneca says antibody treatment failed to prevent Covid-19 in patients exposed to virus
Anglo-Swedish drugmaker AstraZeneca said on Tuesday a study of its monoclonal antibody treatment, AZD7442, did not meet the main goal of preventing symptomatic Covid-19 in people...
GSK, iTeos to develop cancer drug in $2bn deal
Pharma giant GlaxoSmithKline has agreed to pay up to $2 billion to iTeos Therapeutics Inc to develop and sell a potential cancer treatment together,...
Johnson delays Covid reopening by a month
Prime Minister Boris Johnson delayed his plans to lift most remaining Covid-19 restrictions by a month on Monday (June 14), warning that thousands more people might die if he...
Novavax Covid-19 vaccine 93pc effective; offers total protection against ‘moderate and severe’ disease
Novavax’s Covid vaccine, NVX-CoV2373, has demonstrated 100 per cent protection against “moderate and severe disease”, the company said in a press release on Monday (June...
Pharmacists’ training requirements for 2021-22 flu season reinstated
Normal training requirements for pharmacists providing the annual flu vaccination service are being reinstated for the 2021-22 season.
It means pharmacists who are due to...
UK scientists develop gadget that sniffs out Covid-19
Electronic devices may soon be used to identify the presence of infection in a crowded space using body odour profiles after scientists in the...